(Q58452069)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16764340%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

title

Response to interferon-beta therapy in relapsing-remitting multiple sclerosis: a comparison of different clinical criteria (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16764340%20AND%20SRC:MED&resulttype=core&format=json

relapsing-remitting multiple sclerosis

29 January 2020

main subject

multiple sclerosis

0 references

0 references

author

Sandro Sorbi

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16764340%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

Maria Pia Amato

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16764340%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

author name string

E Portaccio

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16764340%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

V Zipoli

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16764340%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

G Siracusa

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16764340%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

publication date

1 June 2006

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16764340%20AND%20SRC:MED&resulttype=core&format=json

Multiple Sclerosis Journal

29 January 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16764340%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

volume

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16764340%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

issue

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16764340%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

page(s)

281-286

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16764340%20AND%20SRC:MED&resulttype=core&format=json

Intramuscular interferon beta-1a for disease progression in relapsing multiple sclerosis. The Multiple Sclerosis Collaborative Research Group (MSCRG)

29 January 2020

cites work

1 reference

https://api.crossref.org/works/10.1191%2F135248506MS1278OA

Randomised double-blind placebo-controlled study of interferon β-1a in relapsing/remitting multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F135248506MS1278OA

PRISMS-4: Long-term efficacy of interferon-beta-1a in relapsing MS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F135248506MS1278OA

A 6-year clinical and MRI follow-up study of patients with relapsing-remitting multiple sclerosis treated with Interferon-beta.

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F135248506MS1278OA

A post-marketing study on interferon beta 1b and 1a treatment in relapsing-remitting multiple sclerosis: different response in drop-outs and treated patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F135248506MS1278OA

Interferon beta in multiple sclerosis: experience in a British specialist multiple sclerosis centre

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F135248506MS1278OA

Interferon beta in relapsing-remitting multiple sclerosis: an independent postmarketing study in southern Italy

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F135248506MS1278OA

A retrospective, observational study comparing the four available immunomodulatory treatments for relapsing-remitting multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F135248506MS1278OA

Clinical characteristics of responders to interferon therapy for relapsing MS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F135248506MS1278OA

Defining interferon beta response status in multiple sclerosis patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F135248506MS1278OA

Assessment of different treatment failure criteria in a cohort of relapsing-remitting multiple sclerosis patients treated with interferon β: Implications for clinical trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F135248506MS1278OA

New diagnostic criteria for multiple sclerosis: guidelines for research protocols

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F135248506MS1278OA

Rating neurologic impairment in multiple sclerosis: An expanded disability status scale (EDSS)

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F135248506MS1278OA

PROBLEMS OF EXPERIMENTAL TRIALS OF THERAPY IN MULTIPLE SCLEROSIS: REPORT BY THE PANEL ON THE EVALUATION OF EXPERIMENTAL TRIALS OF THERAPY IN MULTIPLE SCLEROSIS

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F135248506MS1278OA

Every-other-day interferon beta-1b versus once-weekly interferon beta-1a for multiple sclerosis: results of a 2-year prospective randomised multicentre study (INCOMIN).

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F135248506MS1278OA

Disease modifying therapies in multiple sclerosis: report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology and the MS Council for Clinical Practice Guidelines

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F135248506MS1278OA

Neutralizing antibodies reduce the efficacy of betaIFN during treatment of multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F135248506MS1278OA

Immunogenicity of interferon beta: differences among products

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F135248506MS1278OA

10.1191/135248506MS1278OA

21 January 2018

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16764340%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

1 reference